Search research articles
Contact Us
Filters
Showing results (141-150 of 344) with videos related to
Page
of 35
Sort By:
Clinical Colorectal Cancer
|
October 27, 2016
Prophylactic Use of Oral Dexamethasone to Alleviate Fatigue During Regorafenib Treatment for Patients With Metastatic Colorectal Cancer
Shota Fukuoka, Kohei Shitara, Masaaki Noguchi, et al.
Cancer Chemotherapy and Pharmacology
|
April 3, 2020
Phase 1 study of napabucasin, a cancer stemness inhibitor, in patients with advanced solid tumors
Akihito Kawazoe, Yasutoshi Kuboki, Hideaki Bando, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
January 2, 2007
[Combination chemotherapy with hepatic arterial infusion of 5-fluorouracil (5-FU) and systemic irinotecan (CPT-11) in patients with unresectable liver metastases from colorectal cancer]
Kohei Shitara, Masaki Munakata, Toshihiro Kudo, et al.
Oncology Letters
|
August 7, 2012
Pathological complete response of colorectal liver metastases following chemotherapy with S-1 and oxaliplatin (SOX) in combination with bevacizumab: A case report
Tomoya Yokota, Tsuyoshi Sano, Yasuhiro Shimizu, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
September 16, 2025
Development and validation of a prognostic model incorporating patient reported outcomes for advanced gastric and esophageal carcinoma (AGOC) using individual patient data from two AGITG randomized clinical trials
Sayeda Kamrun Naher, David Espinoza, Peter Grimison, et al.
Targeted Oncology
|
February 7, 2019
Phase I Study of the Focal Adhesion Kinase Inhibitor BI 853520 in Japanese and Taiwanese Patients with Advanced or Metastatic Solid Tumors
Toshihiko Doi, James Chih-Hsin Yang, Kohei Shitara, et al.
Anticancer Research
|
October 4, 2011
Docetaxel plus 5-fluorouracil and cisplatin (DCF) induction chemotherapy for locally advanced borderline-resectable T4 esophageal cancer
Tomoya Yokota, Shunzo Hatooka, Takashi Ura, et al.
Japanese Journal of Clinical Oncology
|
November 12, 2010
Randomized phase II study comparing dose escalated weekly paclitaxel vs. standard dose weekly paclitaxel for patients with previously treated advanced gastric cancer
Kohei Shitara, Isao Oze, Ayako Mizota, et al.
Cancer Science
|
July 15, 2022
Phase I study of the irreversible fibroblast growth factor receptor 1-4 inhibitor futibatinib in Japanese patients with advanced solid tumors
Toshihiko Doi, Kohei Shitara, Takashi Kojima, et al.
Investigational New Drugs
|
March 17, 2015
Clinical outcomes in 66 patients with advanced gastric cancer treated in phase I trials: the NCCHE experience
Akihito Kawazoe, Kohei Shitara, Shota Fukuoka, et al.
Page
of 35
Search research articles
Search
Showing results (141-150 of 344) with videos related to
Sort By:
Page
of 35
Clinical Colorectal Cancer
|
October 27, 2016
Prophylactic Use of Oral Dexamethasone to Alleviate Fatigue During Regorafenib Treatment for Patients With Metastatic Colorectal Cancer
Shota Fukuoka, Kohei Shitara, Masaaki Noguchi, et al.
Cancer Chemotherapy and Pharmacology
|
April 3, 2020
Phase 1 study of napabucasin, a cancer stemness inhibitor, in patients with advanced solid tumors
Akihito Kawazoe, Yasutoshi Kuboki, Hideaki Bando, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
January 2, 2007
[Combination chemotherapy with hepatic arterial infusion of 5-fluorouracil (5-FU) and systemic irinotecan (CPT-11) in patients with unresectable liver metastases from colorectal cancer]
Kohei Shitara, Masaki Munakata, Toshihiro Kudo, et al.
Oncology Letters
|
August 7, 2012
Pathological complete response of colorectal liver metastases following chemotherapy with S-1 and oxaliplatin (SOX) in combination with bevacizumab: A case report
Tomoya Yokota, Tsuyoshi Sano, Yasuhiro Shimizu, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
September 16, 2025
Development and validation of a prognostic model incorporating patient reported outcomes for advanced gastric and esophageal carcinoma (AGOC) using individual patient data from two AGITG randomized clinical trials
Sayeda Kamrun Naher, David Espinoza, Peter Grimison, et al.
Targeted Oncology
|
February 7, 2019
Phase I Study of the Focal Adhesion Kinase Inhibitor BI 853520 in Japanese and Taiwanese Patients with Advanced or Metastatic Solid Tumors
Toshihiko Doi, James Chih-Hsin Yang, Kohei Shitara, et al.
Anticancer Research
|
October 4, 2011
Docetaxel plus 5-fluorouracil and cisplatin (DCF) induction chemotherapy for locally advanced borderline-resectable T4 esophageal cancer
Tomoya Yokota, Shunzo Hatooka, Takashi Ura, et al.
Japanese Journal of Clinical Oncology
|
November 12, 2010
Randomized phase II study comparing dose escalated weekly paclitaxel vs. standard dose weekly paclitaxel for patients with previously treated advanced gastric cancer
Kohei Shitara, Isao Oze, Ayako Mizota, et al.
Cancer Science
|
July 15, 2022
Phase I study of the irreversible fibroblast growth factor receptor 1-4 inhibitor futibatinib in Japanese patients with advanced solid tumors
Toshihiko Doi, Kohei Shitara, Takashi Kojima, et al.
Investigational New Drugs
|
March 17, 2015
Clinical outcomes in 66 patients with advanced gastric cancer treated in phase I trials: the NCCHE experience
Akihito Kawazoe, Kohei Shitara, Shota Fukuoka, et al.
Page
of 35